Disease/Infection News

RSS

Development of a plant-based platform for the production of SARS-CoV-2 antigen

Scientists have recently focused on the development of plant-based recombinant protein platforms.

21 Oct 2021

Immune responses to SARS-CoV-2 infection and vaccination in patients with multiple sclerosis

A new study has focused on the immune response in pwMS undergoing anti-CD20 treatment.

21 Oct 2021

New system aims to maximize protection, minimize costs while planning epidemic interventions

A team of researchers has created a software system designed to model epidemics, with the aim of maximizing public-health protections while minimizing economic and social costs.

21 Oct 2021

Oxford vaccine trial participants believe the COVID-19 vaccine must be a shared global good

National pride in the Oxford-AstraZeneca vaccine does not outweigh desire for global greater good, suggests study with trial participants.

21 Oct 2021

MRI study suggests link between SARS-CoV-2 and brain lesions in COVID-19 patients with pneumonia

New research suggests pneumonia in COVID-19 patients is linked to viral-induced changes in the brain. MRI scans revealed 57.9% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients had recent brain lesions.

20 Oct 2021

Study explores cross-cultural differences in knowledge, attitude towards COVID-19

A study exploring cross-cultural differences in knowledge and attitudes towards COVID-19 reveals that people in Europe had the least knowledge of COVID-19 and lowest tendency to care about the coronavirus, while people in the United States had the lowest tendency to comply with public health restrictions.

20 Oct 2021

Broadly protective vaccines against coronaviruses needed to protect against future outbreaks

The coronavirus disease 2019 (COVID-19) pandemic, caused by the β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alerted the world to the seriousness of the threat posed by novel viruses.

20 Oct 2021

How the public views COVID-19 vaccines via Twitter in the United States

A new study uses Twitter to examine public attitudes towards the vaccines developed to fight the COVID-19 in the United States.

20 Oct 2021

New shorter treatment regimen found to be safer, more effective at treating drug-resistant TB

A new all-oral six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) than the current accepted standard of care, according to results announced at the 52nd Union World Conference on Lung Health.

20 Oct 2021

Researchers launch new project for improving the ability to predict, respond to future pandemics

A multidisciplinary national research team led by University of Utah Health scientists has launched a comprehensive review and analysis of data collected about COVID-19 in hopes of improving the nation’s ability to predict, detect, and respond to future pandemics.

20 Oct 2021

Children show lower seroconversion rates than adults with mild COVID-19

A new study finds that following mild COVID-19, children are more likely to remain seronegative than adults, irrespective of the viral load or symptom severity.

20 Oct 2021

New research on phagocytosis and SARS-CoV-2's spike protein

A new study showed that convalescent patient plasma and monoclonal anti-spike antibodies were able to induce phagocytosis at high antibody concentrations.

20 Oct 2021

Biomarker predicts severity of SARS-CoV-2 infection in patients

A new study investigates a biomarker to predict the severity of disease in patients infected with SARS-CoV-2.

20 Oct 2021

The neutralization potential of nanobodies against SARS-CoV-2

A recent review describes the role of nanobodies as a new class of recombinant antibodies that are used in the treatment of COVID-19.

20 Oct 2021

New oligomer shows promising anti-SARS-CoV-2 properties

Scientists from the University Of New Mexico have recently identified a new cationic oligomer that may help inactivate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

20 Oct 2021

UK government announces deals to secure two new COVID-19 treatments

Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government announced deals to secure two new treatments.

20 Oct 2021

Scientists search for cause of mysterious covid-related inflammation in children

Like most other kids with covid, Dante and Michael DeMaino seemed to have no serious symptoms.

20 Oct 2021

Two doses of Pfizer-BioNTech vaccine effective in preventing COVID-19 hospitalization among adolescents

The Centres for Disease Control and Prevention conducted a study to determine the vaccination efficacy in the adolescent population, published recently.

20 Oct 2021

COVID-19 vaccination side effects in the USA

A new study described and compared self-reported side effects of three different COVID-19 vaccines administered between March 19 and July 15, 2021, in the United States.

20 Oct 2021

Suggested mechanism of SARS-CoV-2 infection inhibition by Mitoxantrone

A group of researchers performed a drug repurposing screen on an FDA-approved anti-cancer drug named Mitoxantrone.

20 Oct 2021

Disease/Infection News

Development of a plant-based platform for the production of SARS-CoV-2 antigen

Immune responses to SARS-CoV-2 infection and vaccination in patients with multiple sclerosis

New system aims to maximize protection, minimize costs while planning epidemic interventions

Oxford vaccine trial participants believe the COVID-19 vaccine must be a shared global good

MRI study suggests link between SARS-CoV-2 and brain lesions in COVID-19 patients with pneumonia

Study explores cross-cultural differences in knowledge, attitude towards COVID-19

Broadly protective vaccines against coronaviruses needed to protect against future outbreaks

How the public views COVID-19 vaccines via Twitter in the United States

New shorter treatment regimen found to be safer, more effective at treating drug-resistant TB

Researchers launch new project for improving the ability to predict, respond to future pandemics

Children show lower seroconversion rates than adults with mild COVID-19

New research on phagocytosis and SARS-CoV-2's spike protein

Biomarker predicts severity of SARS-CoV-2 infection in patients

The neutralization potential of nanobodies against SARS-CoV-2

New oligomer shows promising anti-SARS-CoV-2 properties

UK government announces deals to secure two new COVID-19 treatments

Scientists search for cause of mysterious covid-related inflammation in children

Two doses of Pfizer-BioNTech vaccine effective in preventing COVID-19 hospitalization among adolescents

COVID-19 vaccination side effects in the USA

Suggested mechanism of SARS-CoV-2 infection inhibition by Mitoxantrone

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News